Notification Shareholders - Subscription Rights
Summary by AI BETAClose X
10 April 2026
GEIGER COUNTER LIMITED
(THE "COMPANY")
Notification to Shareholders in regard to Subscription Rights
Please be reminded that you have the right to subscribe for Ordinary Shares in the Company in cash on the basis of one new Ordinary Share for every five existing Ordinary Shares held on 9 April 2026, exercisable on 30 April, at a price of 37.20 pence per share (being the price equal to the audited undiluted net asset value of an Ordinary share on 1 May 2025).
The Subscription Price is, at present, materially below the current share price
The deadline to submit your instructions is 1pm on Friday 24 April 2026 for the Fifth Annual Subscription Date.
If you hold your Ordinary Shares in uncertificated form, you will be allocated Subscription Right entitlements in CREST on 13 April 2026 by reference to your shareholding as at close of business on 9 April 2026 (the Record Date). Market claims will not be switched on in CREST, which was the case for previous events.
If you hold your shares in certificated form you should return an application form and a payment as instructed in the form to Computershare Investor Services PLC, Corporate Actions, The Pavilions, Bridgwater Road, Bristol BS99 6AH.
Ordinary Shares issued pursuant to the exercise of Subscription Rights will be allotted within 14 Business Days of the relevant Subscription Date.
A notice has been sent to all Shareholders and is available from the Company's website:
https://ncim.co.uk/geiger-counter-ltd/
In addition, a copy of the notice has been submitted to the National Storage Mechanism and will shortly be available for inspection at https://data.fca.org.uk/#/nsm/nationalstoragemechanism.
Enquiries
|
Manulife | CQS Investment Management |
Craig Cleland |
T: +44 (0) 20 7201 5368] |
|
Cavendish Capital Markets Limited |
Tunga Chigovanyika (Corporate Finance) |
T: +44 (0) 20 7397 1915 |
|
|
Daniel Balabanoff / Pauline Tribe (Sales) |
T: +44 (0) 20 7220 0500 |
|
Summit Fund Services Jersey Limited |
Christopher Foulds |
T:+44 (0) 1534 825 259 |
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Latest directors dealings
- 6 hours ago Luceco
- 6 hours ago Helios Towers
- 6 hours ago Wise Class A
- 6 hours ago EDX Medical Group Plc
- 7 hours ago Naked Wines